Michael H. Mulroy
Independent ChairmanMr. Michael H. Mulroy, also known as Mike, J.D., serves as Director of LifeMap Solutions, Inc. since November 2015. He is also a member of the BioTime Board of Directors. He serves as the President of Mulroy Advisors, LLC. Mr. Mulroy had been the Chief Executive Officer at Asterias Biotherapeutics, Inc since June 26, 2017 and served as its President since June 26, 2017 and had been its Director. He has experience as a strategic planner and as legal counsel and member of a senior management team of a growing biopharmaceutical company. Mr. Mulroy has experience in corporate finance and investor relations. He served as a Senior Advisor to CamberView Partners, LLC. Mr. Mulroy served as Executive Vice President of Strategic Affairs and General Counsel of the Autoimmune and Rare Diseases Business Unit of Mallinckrodt plc until September 2014. He served as an Executive Vice President of Strategic Affairs at Questcor Pharmaceuticals, Inc. since February 17, 2014. Mr. Mulroy served as General Counsel and Secretary of Questcor Pharmaceuticals, Inc. since January 2011 and corporate counsel since 2005. At Questcor, Mr. Mulroy served in various capacities from January 2011 to September 2014. He served as the Chief Financial Officer of Questcor Pharmaceuticals, Inc. from January 2011 to February 17, 2014; as Executive Vice President from July 31, 2013 to February 17, 2014 and Principal Accounting Officer from September 26, 2011 to February 17, 2014. He was a Partner of Stradling Yocca Carlson & Rauth, P.C since 2004. He served at Stradling Yocca from 2003 to 2011, where he represented Questcor and other publicly-traded companies. From 1997 to 2003, Mr. Mulroy was an Investment Banker at Merrill Lynch and Citigroup from 1997 to 2003, where he advised healthcare companies and other clients across a range of industries in connection with corporate finance and strategic transactions. He has been an Independent Director of Lineage Cell Therapeutics, Inc. (formerly known as BioTime, Inc.) since October 06, 2014 and serves as its Chairman since April 27, 2024. He joined the Lineage Cell Therapeutics, Inc. on October 06, 2014. He served as Director of Asterias Biotherapeutics, Inc. from June 26, 2017 to March 8, 2019. He serves as a Director of privately-held Magtrol Inc. He served as a Director of AgeX Therapeutics, Inc. since January 2017 until July 30, 2019. He served as an Independent Director of Comarco, Inc. from July 21, 2011 to August 25, 2014. Mr. Mulroy is a Member of the State Bar of California and the Orange County Bar Association, Business Section. He is a business consultant. He earned his J.D. Degree from the University of California, Los Angeles and his B.A. in Economics from the University of Chicago.
Positions
- Company NameLineage Cell Therapeutics, Inc.Stock CodeLCTXPositionIndependent ChairmanColleagues
- BMBrian M. CulleyCEO, President & Director
- JAJill Ann HoweChief Financial Officer
- GAGeorge A. SamuelGeneral Counsel & Company Secretary
- ICIoana C. HoneVP of Corporate Communications & Director of Investor Relations
- CHCharlotte HubbertVice President of Corporate Strategy & Development
- NCNeal Clifton BradsherIndependent Director
- DJDeborah J. AndrewsIndependent Director
- ACAngus C. RussellIndependent Director
